StonvexLoading…
StonvexStonvexStonvexCore line items from GRMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $1.75B | $7.25B | $5.12B | $3.35B |
Operating Income | $431.67M | $1.88B | $1.26B | $805.12M |
Net Income | $405.08M | $1.66B | $1.14B | $733.59M |
EPS (Diluted) | $2.09 | $8.59 | $5.87 | $3.79 |
Total Assets | $10.95B | $10.99B | $10.52B | $10.32B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.29B | $2.28B | $2.07B | $2.07B |
Free Cash Flow OCF − CapEx | $469.37M | $1.36B | $933.30M | $508.22M |
Shares Outstanding | 192.90M | 192.62M | 192.38M | 192.54M |